SOX2 and cancer: An essential modulator of stemness, SOX2, has been consistently identified as a promoting factor for CSC-like properties in diverse cancer types including LUAD, but conflicting findings have been reported concerning the impact of SOX2 on patient survival in LUAD [9,24].